Zhang, P., Tong, Z., Tian, F., Wang, Y., Yang, J., Li, W., . . . Xu, B. (2016). Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients. J Hematol Oncol.
Chicago Style CitationZhang, Pin, et al. "Phase II Trial of Utidelone As Monotherapy or in Combination With Capecitabine in Heavily Pretreated Metastatic Breast Cancer Patients." J Hematol Oncol 2016.
Cita MLAZhang, Pin, et al. "Phase II Trial of Utidelone As Monotherapy or in Combination With Capecitabine in Heavily Pretreated Metastatic Breast Cancer Patients." J Hematol Oncol 2016.
Atenció: Aquestes cites poden no estar 100% correctes.